Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 1;5:11650. doi: 10.1038/srep11650

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015, Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) Relative cell viability of breast cancer cells after AMO treatments. SK-BR-3 cells were treated with AMO-miR-100 or AMO-miR-100-scrambled at different concentrations. Forty-eight h later, the cell viability was detected. (B) Effects of miR-100 silencing on breast cancer chemotherapy. SK-BR-3 cells were simultaneously treated with AMO and Cisplatin at different concentrations. Subsequently, the cell viability was evaluated. (C) Caspase 3/7 activity analysis from breast cancer cells. SK-BR-3 cells were treated with AMO and Cisplatin. Forty-eight h later the caspase 3/7 activity of cells was analysed. The statistically significant differences between different treatments were indicated with asterisks (*p < 0.05).